Evidence map›Paper›PMID 31612301›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2020

Chronic performance of subxiphoid minimally invasive pericardial Model 20066 pacemaker lead insertion in an infant animal model.

Bradley C Clark, Rohan Kumthekar, Paige Mass, Justin D Opfermann, Charles I Berul

Abstract read
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Safety and performance of a novel subxiphoidal pacemaker system.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Expanding the Reach of Pediatric Transcatheter Pacing.The Journal of innovations in cardiac rhythm management · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bradley C ClarkChildren's Hospital at Montefiore, 3415 Bainbridge Avenue, Bronx, NY, 10467, USA. bradleyclarkep@gmail.com.ORCID http://orcid.org/0000-0002-8186-8471
Rohan KumthekarChildren's National Medical Center, Washington, DC, USA.
Paige MassSheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC, USA.
Justin D OpfermannSheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC, USA.
Charles I BerulChildren's National Medical Center, Washington, DC, USA.

Funding

PeriPath: A Novel Pericardial Access Tool for Epicardial Pacing and DefibrillationR43HL144352 · NHLBI · PERICOR, LLC · PI BERUL, CHARLES I, OPFERMANN, JUSTIN · 2018 to 2018
$225k
NHLBI NIH HHS R43 HL144352
6 · The paper itself

Abstract

purposeTo describe chronic performance of subxiphoid minimally invasive pacemaker lead insertion in a piglet model.

methodsMinimally invasive pacemaker lead implantation was performed through a 10-mm incision under direct visualization using the PeriPath port. Epicardial access was obtained and the commercially available Medtronic Model 20066 pacemaker lead was inserted into the pericardial space and epicardial fixation was performed using the side-action helix. The lead was connected to a pacemaker generator in a para-rectus pocket. Animals underwent a 12-14-week observation period and lead impedances, R-wave amplitudes, and ventricular capture thresholds were tested biweekly. After the survival period, animals were euthanized and gross and histopathology were performed.

resultsSubxiphoid minimally invasive pacemaker lead placement was performed in 8 animals (median 4.9 kg) with 100% acute success. Median procedure time was 65 min (IQR 60.5-77). At implant, median lead impedance was 650 Ω (IQR 244-984), R-wave amplitude 11.1 mV (IQR 8-12.3), and ventricular capture threshold 1.5 V @ 0.4 ms (IQR 1-2.6). Over a median survival period of 13 weeks, there was a median lead impedance change of + 262 Ω (IQR 5.3-618.3), R-wave change of - 4.5 mV (IQR - 7.1-- 2.7) and capture threshold change (1.0 ms) of + 1.5 V (IQR 0-3.3). At autopsy, epicardial fixation sites showed fibrovascular proliferation and minimal chronic inflammation.

conclusionsSubxiphoid pericardial pacemaker placement is safe and effective in a piglet model. Further study and development of leads designed for pericardial placement are warranted.

Indexed as

Minimally Invasive Surgical ProceduresPacemaker, ArtificialAnimalsDisease Models, AnimalElectrodes, ImplantedHumansPericardiumSwineAnimal modelMinimally invasivePacemakerPericardialSubxiphoid

Identifiers

PMID31612301
PMCPMC7273738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.